These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 7674685)

  • 21. Management of patients with chronic stable angina at low risk for serious cardiac events.
    Thadani U
    Am J Cardiol; 1997 Jun; 79(12B):24-30. PubMed ID: 9223354
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence and patterns of silent myocardial ischemia during daily life in stable angina patients receiving conventional antianginal drug therapy.
    Deedwania PC; Carbajal EV
    Am J Cardiol; 1990 May; 65(16):1090-6. PubMed ID: 1970449
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Additional antianginal and anti-ischemic efficacy of mibefradil in patients pretreated with a beta blocker for chronic stable angina pectoris.
    Alpert JS; Kobrin I; DeQuattro V; Friedman R; Shepherd A; Fenster PE; Thadani U
    Am J Cardiol; 1997 Apr; 79(8):1025-30. PubMed ID: 9114758
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Anti-angina therapy of coronary heart disease. Mono- or combination treatment].
    Kurz T; Rauch B; Kübler W
    Z Kardiol; 1991 May; 80(5):305-16. PubMed ID: 1678565
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antianginal and anti-ischemic effects of mibefradil in the treatment of patients with chronic stable angina pectoris.
    Alpert JS; Bakx AL; Braun S; Frishman WH; Schneeweiss A; Tzivoni D; Kobrin I
    Am J Cardiol; 1997 Aug; 80(4B):20C-26C. PubMed ID: 9286850
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Optimal treatment of stable angina.
    Parmley WW
    Cardiology; 1997; 88 Suppl 3():27-31. PubMed ID: 9397290
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Trimetazidine. A review of its use in stable angina pectoris and other coronary conditions.
    McClellan KJ; Plosker GL
    Drugs; 1999 Jul; 58(1):143-57. PubMed ID: 10439934
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Suboptimal pharmacotherapeutic management of chronic stable angina in the primary care setting.
    Wiest FC; Bryson CL; Burman M; McDonell MB; Henikoff JG; Fihn SD
    Am J Med; 2004 Aug; 117(4):234-41. PubMed ID: 15308432
    [TBL] [Abstract][Full Text] [Related]  

  • 29. API expert consensus document on management of ischemic heart disease.
    Association of Physicians of India
    J Assoc Physicians India; 2006 Jun; 54():469-80. PubMed ID: 16909697
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Various aspects of drug therapy of chronic forms of ischemic heart disease].
    Kipshidze NN; Chumburidze VB
    Kardiologiia; 1985 Sep; 25(9):37-40. PubMed ID: 2867241
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Efficacy and tolerance of trimetazidine, a metabolic antianginal, in combination with a hemodynamic antianginal in stable exertion angina. TRIMPOL I, a multicenter study].
    Szwed H; Pachocki R; Domzal-Bochenska M; Szymczak K; Szydlowski Z; Paradowski A; Gajos G; Kaluza G; Kulon I; Wator-Brzezińska A; Elikowski W; Kuźniak M
    Presse Med; 2000 Mar; 29(10):533-8. PubMed ID: 10761517
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antianginal drug therapy for silent myocardial ischemia.
    Frishman WH; Teicher M
    Med Clin North Am; 1988 Jan; 72(1):185-96. PubMed ID: 3276984
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Emerging options in the management of myocardial ischemia.
    Mehta JL
    Am J Cardiol; 1994 Jan; 73(3):18A-27A. PubMed ID: 7906091
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical aspects of silent myocardial ischemia in patients with angina and other forms of coronary heart disease.
    Pepine CJ
    Am J Med; 1986 Apr; 80(4C):25-34. PubMed ID: 2871755
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Meta-analysis of trials comparing beta-blockers, calcium antagonists, and nitrates for stable angina.
    Heidenreich PA; McDonald KM; Hastie T; Fadel B; Hagan V; Lee BK; Hlatky MA
    JAMA; 1999 May; 281(20):1927-36. PubMed ID: 10349897
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Current medical management of chronic stable angina.
    Thadani U
    J Cardiovasc Pharmacol Ther; 2004 Sep; 9 Suppl 1():S11-29; quiz S98-9. PubMed ID: 15378129
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacologic management of ischemic heart disease with beta-blockers and calcium channel blockers.
    Pearle DL
    Am Heart J; 1990 Sep; 120(3):739-42; discussion 743-5. PubMed ID: 1975155
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Management and outcomes of non-ST elevation acute coronary syndromes in relation to previous use of antianginal therapies (from the Canadian Global Registry of Acute Coronary Events [GRACE] and Canadian Registry of Acute Coronary Events [CANRACE]).
    Kang JS; Goodman SG; Yan RT; Lopez-Sendon J; Pesant Y; Graham JJ; Fitchett D; Wong GC; Rose BF; Spencer FA; Yan AT;
    Am J Cardiol; 2013 Jul; 112(1):51-6. PubMed ID: 23582629
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacologic therapy of angina pectoris.
    Zavecz JH; Bueno O
    J La State Med Soc; 1995 May; 147(5):208-10, 213-6. PubMed ID: 7782675
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment strategies for daily life silent myocardial ischemia: a correlation with potential pathogenic mechanisms.
    Bertolet BD; Hill JA; Pepine CJ
    Prog Cardiovasc Dis; 1992; 35(2):97-118. PubMed ID: 1355607
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.